1-3 of 3
Xuexiang Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exploring the main mechanisms of anti-tumor and immunotherapy-related adverse events for safer and effective anti-CTLA-4 immunotherapy

Xuexiang Du, Mingyue Liu, Yan Zhang, Fei Tang, Pan Zheng, Yang Liu
Journal: The Journal of Immunology
J Immunol (2020) 204 (1_Supplement): 244.10.
https://doi.org/10.4049/jimmunol.204.Supp.244.10
Published: 01 May 2020
View article titled, Exploring the main mechanisms of anti-tumor and immunotherapy-related adverse events for safer and effective anti-CTLA-4 immunotherapy
Add to Citation Manager
Journal Articles

Uncoupling Therapeutic from Immunotherapy-related Adverse Effects for Safer and Effective Anti-CTLA-4 Antibodies in CTLA4 Humanized Mice

XUEXIANG DU, Fei Tang, Mingyue Liu, Yang Liu, Pan Zheng
Journal: The Journal of Immunology
J Immunol (2018) 200 (1_Supplement): 57.34.
https://doi.org/10.4049/jimmunol.200.Supp.57.34
Published: 01 May 2018
View article titled, Uncoupling Therapeutic from Immunotherapy-related Adverse Effects for Safer and Effective Anti-CTLA-4 Antibodies in <em>CTLA4</em> Humanized Mice
Add to Citation Manager
Journal Articles

Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype

Meng Xu, Mingyue Liu, Xuexiang Du, Sirui Li, Hang Li, Xiaozhu Li, Ying Li, Yang Wang, Zhihai Qin, Yang-Xin Fu, Shengdian Wang
Journal: The Journal of Immunology
J Immunol (2015) 194 (10): 4997–5006.
https://doi.org/10.4049/jimmunol.1402603
Published: 15 May 2015
View article titled, Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype
Open the PDF for Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype in another window
Add to Citation Manager
Includes: Supplementary data